NCT07459400 The Effect of Peloidotherapy in Young Adults Undergoing Physical Therapy Scoliosis Specific Exercises (PSSE)
| NCT ID | NCT07459400 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gaziosmanpasa Research and Education Hospital |
| Condition | Spine Deformity |
| Study Type | OBSERVATIONAL |
| Enrollment | 54 participants |
| Start Date | 2026-03-23 |
| Primary Completion | 2026-09-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 54 participants in total. It began in 2026-03-23 with a primary completion date of 2026-09-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Scoliosis is a musculoskeletal disorder defined by a three-dimensional spinal deformity that can result in substantial clinical and functional limitations, particularly during adolescence and young adulthood. Affected individuals commonly experience postural asymmetry, muscular imbalance, pain, and diminished quality of life. In conservative management, Physiotherapeutic Scoliosis-Specific Exercises (PSSE) have gained recognition as a fundamental intervention. The primary objectives of PSSE include optimizing spinal alignment, facilitating rotational breathing, and restoring muscular symmetry to improve functional capacity. Evidence from systematic reviews suggests that PSSE, especially the Schroth method, are superior to general exercise programs in improving both radiographic parameters and health-related quality of life.Meta-analytic findings further support the effectiveness of PSSE in reducing curve magnitude and enhancing quality of life outcomes. Among the various PSSE approaches, the Schroth method is one of the most extensively investigated and widely applied in clinical settings. This method incorporates three-dimensional postural correction, targeted breathing techniques, and the development of postural awareness. Randomized controlled trials have demonstrated that Schroth exercises significantly improve SRS-22 quality of life scores and positively influence pain, body image, and overall well-being.Despite these established benefits, pain and muscle tension occurring during exercise sessions may negatively influence adherence to rehabilitation programs. In young adults, pain is a critical factor limiting treatment compliance and restricting engagement in daily activities. Accordingly, adjunctive interventions implemented prior to exercise may enhance exercise tolerance and optimize therapeutic outcomes.Peloidotherapy, which involves the therapeutic application of natural medicinal mud, is commonly used in musculoskeletal rehabilitation due to its analgesic, muscle-relaxant, and circulation-enhancing effects. By alleviating pain and reducing muscular tension, peloidotherapy may facilitate greater participation in exercise programs and support improved clinical outcomes.This study aims to investigate the effects of adjunctive peloidotherapy administered before Schroth-based PSSE in young adults with scoliosis, focusing on pain, exercise adherence, and quality of life, with particular emphasis on SRS-22 measures..
Eligibility Criteria
Inclusion Criteria: * Aged 20-40 years * Diagnosed with idiopathic scoliosis by a specialist physician * Cobb angle between 15-40 degrees * Able to perform PSSE exercises throughout the study period * VAS ≥3 at the start of the study * Has had pain complaints for at least 3 months * Individuals who have agreed in writing to participate in the study Exclusion Criteria: * Individuals who have undergone scoliosis surgery * Individuals with neuromuscular, congenital, or secondary scoliosis * Individuals with rheumatological, inflammatory, or serious chronic diseases (such as cardiopulmonary insufficiency or kidney disease) * Pregnant and breastfeeding women * Conditions in which peloidotherapy is contraindicated (active skin infection, open wound, serious dermatological disease, history of allergic reaction, severe cardiopulmonary, kidney or liver failure, bleeding disorder or anticoagulant use, pregnancy/breastfeeding, and systemic infection) * Individuals with serious psychiatric disorders that may interfere with treatment compliance or affect consent * Individuals receiving additional physical therapy during the study period
Contact & Investigator
Sinem Turkmen Ozoguz, MD
PRINCIPAL INVESTIGATOR
Gaziosmanpasa Training and Research Hospital Physical Rehabilitation Department
Frequently Asked Questions
Who can join the NCT07459400 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Spine Deformity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07459400 currently recruiting?
Yes, NCT07459400 is actively recruiting participants. Contact the research team at turkmen_sinem@hotmail.com for enrollment information.
Where is the NCT07459400 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07459400 clinical trial?
NCT07459400 is sponsored by Gaziosmanpasa Research and Education Hospital. The principal investigator is Sinem Turkmen Ozoguz, MD at Gaziosmanpasa Training and Research Hospital Physical Rehabilitation Department. The trial plans to enroll 54 participants.